Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
OBJECTIVE
We constructed and evaluated reference brain FDG-PET databases for usage by three software programs (Computer-aided diagnosis for dementia (CAD4D), Statistical Parametric Mapping (SPM) and NEUROSTAT), which allow a user-independent detection of dementia-related hypometabolism in patients' brain FDG-PET.


METHODS
Thirty-seven healthy volunteers were scanned in order to construct brain FDG reference databases, which reflect the normal, age-dependent glucose consumption in human brain, using either software. Databases were compared to each other to assess the impact of different stereotactic normalization algorithms used by either software package. In addition, performance of the new reference databases in the detection of altered glucose consumption in the brains of patients was evaluated by calculating statistical maps of regional hypometabolism in FDG-PET of 20 patients with confirmed Alzheimer's dementia (AD) and of 10 non-AD patients. Extent (hypometabolic volume referred to as cluster size) and magnitude (peak z-score) of detected hypometabolism was statistically analyzed.


RESULTS
Differences between the reference databases built by CAD4D, SPM or NEUROSTAT were observed. Due to the different normalization methods, altered spatial FDG patterns were found. When analyzing patient data with the reference databases created using CAD4D, SPM or NEUROSTAT, similar characteristic clusters of hypometabolism in the same brain regions were found in the AD group with either software. However, larger z-scores were observed with CAD4D and NEUROSTAT than those reported by SPM. Better concordance with CAD4D and NEUROSTAT was achieved using the spatially normalized images of SPM and an independent z-score calculation. The three software packages identified the peak z-scores in the same brain region in 11 of 20 AD cases, and there was concordance between CAD4D and SPM in 16 AD subjects.


CONCLUSIONS
The clinical evaluation of brain FDG-PET of 20 AD patients with either CAD4D-, SPM- or NEUROSTAT-generated databases from an identical reference dataset showed similar patterns of hypometabolism in the brain regions known to be involved in AD. The extent of hypometabolism and peak z-score appeared to be influenced by the calculation method used in each software package rather than by different spatial normalization parameters.
Department of Nuclear Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany. hans-georg.buchholz@unimedizin-mainz.de.
Hans-Georg
HG
Buchholz
Philips Research Laboratories, Hamburg, Germany. fabian.wenzel@philips.com.
Fabian
F
Wenzel
Department of Nuclear Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany. martin.gartenschlaeger@unimedizin-mainz.de.
Martin
M
Gartenschläger
Philips Research Laboratories, Aachen, Germany. frank.o.thiele@philips.com.
Frank
F
Thiele
Philips Healthcare, Hamburg, Germany. stewart.young@philips.com.
Stewart
S
Young
Department of Nuclear Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany. stefan.reuss@unimedizin-mainz.de.
Stefan
S
Reuss
Department of Nuclear Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany. mathias.schreckenberger@unimedizin-mainz.de.
Mathias
M
Schreckenberger
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D016022:Case-Control Studies; D016208:Databases, Factual; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D012984:Software
D019788:Fluorodeoxyglucose F18